Table 1.
Baseline characteristics of study participants based on hypertriglyceridemic waist phenotypes
| Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
| n | 18 | 230 | 127 |
| Age (years) | 67 ± 10* | 61 ± 8 | 60 ± 7 |
| BMI (kg/m2) | 24.7 ± 2.8 | 33.0 ± 4.9† | 32.5 ± 4.6† |
| Waist circumference (cm) | 81.4 ± 5.0 | 109.1 ± 12.0† | 108.6 ± 10.9† |
| Duration of type 2 diabetes (months) | 121 ± 159 | 94 ± 83 | 86 ± 79 |
| A1C (%) | 7.0 ± 0.8 | 7.3 ± 0.9 | 7.6 ± 1.1‡ |
| Sex (%) | |||
| Men | 39 | 61 | 65 |
| Women | 61 | 39 | 35 |
| Smoking (%) | |||
| Current | 17 | 15 | 15 |
| Former | 50 | 48 | 54 |
| Never | 33 | 37 | 31 |
| Diabetes therapy (%) | |||
| None | 11 | 12 | 21§ |
| Sulfonylurea | 17 | 16 | 15 |
| Metformin | 28 | 25 | 36§ |
| Sulfonylurea and metformin | 22 | 34 | 25§ |
| Insulin | 22 | 13 | 3§ |
| Statin use (%) | |||
| On statin | 50 | 53 | 60 |
| No statin | 50 | 47 | 40 |
Data are means ± SD or percent. Group 1 (low waist circumference and low triglycerides; waist circumference ≤90 cm in men or ≤85 cm in women and triglycerides <177 mg/dl); group 2 (high waist circumference and low triglycerides; waist circumference >90 cm in men or >85 cm in women and triglycerides <177 mg/dl, n = 230); and group 3 (high waist circumference and high triglycerides; waist circumference >90 cm in men or >85 cm in women and triglyceride ≥177 mg/dl, n = 127).
*P < 0.05 vs. groups 2 and 3;
†P < 0.0001 vs. group 1;
‡P < 0.01 vs. groups 1 and 2;
§P < 0.01 vs. group 2.